Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 1111-1114

  Tugba Kos, F ^a   Sendur, Mehmet Ali Nahit ^b   Aksoy, Sercan ^c   Celik, Huseyin Tugrul ^d   Sezer, Sevilay ^b   Civelek, Burak ^b   Yaman, Sebnem ^b   Zengin, Nurullah ^b  

^a KSU Medical School   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

Author keywords

Chemotherapy; Cisplatin; Neutrophil gelatinase associated lipocalin

Indexed keywords

ACUTE PHASE PROTEIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CISPLATIN; CREATININE; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; DRUG EFFECT; EARLY DIAGNOSIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NEOPLASM; YOUNG ADULT;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CREATININE; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; YOUNG ADULT;

EID: 84877641508     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.1111     Document Type: Article

References (16)

1. Asna N, Lewy H, Ashkenazi IE, et al(2005). Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity. Life Sci, 76, 1825-34.
2. Gaspari F, Cravedi P, Mandalà M, et al(2010). Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study. Nephron Clin Pract, 115, 154-60.
3. Hanigan MH, Devarajan P (2003). Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther, 1, 47-61.
4. Kjeldsen L, Bainton DF, Sengeløv H, Borregaard N (1994). Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood, 83, 799-807.
5. Kuwabara T, Mori K, Mukoyama M, et al(2009). Urinary neutrophil gelatinase- associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int, 75, 285-94.
6. Levey AS, Bosch JP, Lewis JB, et al(1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med, 130, 461-70.
7. Ling W, Zhaohui N, Ben H, et al(2008). Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract, 108, 176-81.
8. Mishra J, Ma Q, Prada A, et al(2003). Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol, 14, 2534-43.
9. Mishra J, Mori K, Ma Q, et al(2004). Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol, 24, 307-15.
10. Mohanram A, Toto R (2005). Measurement of kidney function. In 'Chronic Kidney Disease, Dialysis, and Transplantation. A Companion to Brenner and Rector's The Kidney'. Eds Pereira BJG, Sayegh MH, Blake PG. Philadelphia, Saunders pp.20-30.
11. Parikh CR, Jani A, Mishra J, et al(2006). Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant, 6, 1639-45.
12. Perazella MA, Moeckel GW (2010). Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy. Semin Nephrol, 30, 570-81.
13. Perrone RD, Madias NE, Levy AS (1992). Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem, 38, 1933-53.
14. Shemesh O, Golbetz H, Kriss JP, Myers BD (1985). Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int, 28, 830-8.
15. Townsend DM, Deng M, Zhang L, Lapus MG, Hanigan MH (2003). Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol, 14, 1-10.
16. Wagener G, Jan M, Kim M, et al(2006). Association between increases in urinary neutrophil-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology, 105, 485-91.